| 产品描述: | GGTI-2154 hydrochloride is a potent and selective inhibitor geranylgeranyltransferase I (GGTase I), with an IC50 of 21 nM. GGTI-2154 hydrochloride shows more than 200-fold selectivity for GGTase I over FTase (IC50=5600 nM). GGTI-2154 hydrochloride can be used for the research of cancer. |
| 体外研究: |
GGTI-2154 (100 mg/kg/天;皮下注射 14 天) 在 MMTV-ν-Ha-Ras 转基因小鼠中诱导乳腺肿瘤消退[2]。 GGTI-2154 (50 mg/kg/天;腹腔注射 50 天) 抑制裸鼠 A-549 肿瘤生长 60%[1]。 |
| 体内研究: |
GGTI-2154 抑制香叶基香叶基从[3H]GGPP 转移到 H-Ras CVLL,IC50 为 21 nM。 |
| 参考文献: |
1. Sun J, et, al. Antitumor efficacy of a novel class of non-thiol-containing peptidomimetic inhibitors of farnesyltransferase and geranylgeranyltransferase I: combination therapy with the cytotoxic agents cisplatin, Taxol, and gemcitabine. Cancer Res. 1999 Oct 1;59(19):4919-26. 2. Sun J, et, al. Geranylgeranyltransferase I inhibitor GGTI-2154 induces breast carcinoma apoptosis and tumor regression in H-Ras transgenic mice. Cancer Res. 2003 Dec 15;63(24):8922-9. |
| 保存条件: |
-80°C 12个月; -20°C 6个月, 干燥 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.188 ml |
10.942 ml |
21.883 ml |
| 5 mM |
0.438 ml |
2.188 ml |
4.377 ml |
| 10 mM |
0.219 ml |
1.094 ml |
2.188 ml |
| 50 mM |
0.044 ml |
0.219 ml |
0.438 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |